VelaVigo Announced Completion of Pre-A Round of Financing of Nearly $ 50 Million
2024-12-31

VelaVigo Announced Completion of Pre-A Round of Financing of Nearly $ 50 Million

VelaVigo Cayman Limited had completed the pre-A round of financing of nearly $50 million, existing shareholder HLC continuing to support
Ikena Oncology and Inmagene Announce Merger and Fundraising
2024-12-23

Ikena Oncology and Inmagene Announce Merger and Fundraising

Ikena Oncology and Inmagene Biopharmaceuticals announced they have entered into a definitive merger agreement
Rgenta Therapeutics Announces Strategic Alliance with GSK
2024-12-04

Rgenta Therapeutics Announces Strategic Alliance with GSK

Rgenta Therapeutics announced that it has entered into a multi-year, multi-target strategic research alliance with pharma giant GSK
GenScript to Receive Significant Revenue through its Involvement in $3.3 Billion Deal with Merck
2024-11-15

GenScript to Receive Significant Revenue through its Involvement in $3.3 Billion Deal with Merck

GenScript Biotech announced that its CDMO subsidiary, ProBio, has licensed its PD-1 new molecular entity (NME) to LaNova Medicines
Pulmatrix and Cullgen Announce Proposed Merger
2024-11-13

Pulmatrix and Cullgen Announce Proposed Merger

Pulmatrix and Cullgen have announced a merger to form a Nasdaq-listed entity, focusing on targeted protein degradation
BioNTech to Acquire China’s Biotheus for USD800 Million
2024-11-13

BioNTech to Acquire China’s Biotheus for USD800 Million

BioNTech has reached an agreement to acquire Chinese biopharmaceutical company Biotheus for $800 million
  • 1
  • 2
  • 3
  • 4
  • 5
  • 29 records in total